论文部分内容阅读
目的:探讨静脉与口服联合应用胺碘酮行心房颤动复律的临床疗效。方法:回顾性分析应用静脉与口服联合应用碘酮复律的46例心房颤动患者的临床资料。结果:46例患者中31例恢复为窦律,转复成功率为67.4%;复律失败的患者中,10例心室率减慢至80次/min以内,5例完全无效。随访37例,随访期为2~41(平均12±3.6)个月,其中21例以胺碘酮口服维持,房颤症状控制良好,无室颤、室速及猝死病例。结论:静脉与口服联合应用胺碘酮行心房颤动复律,疗效可靠,不良反应少,值得推广。
Objective: To investigate the clinical effect of intravenous and oral administration of amiodarone on cardioversion of atrial fibrillation. Methods: The clinical data of 46 patients with atrial fibrillation treated with intravenous and oral administration of iodine-ketone cardioversion were retrospectively analyzed. Results: Among the 46 patients, 31 cases recovered to sinus rhythm, and the successful rate of conversion was 67.4%. Among the patients with failed cardioversion, the ventricular rate was reduced to 80 beats / min in 10 patients and 5 patients were completely ineffective. Follow-up was performed in 37 cases. The follow-up period ranged from 2 to 41 (mean 12 ± 3.6) months. 21 of them were orally administered with amiodarone. The symptoms of atrial fibrillation were well controlled without VF, VT and sudden death. Conclusion: Amiodarone combined with intravenous and oral administration of atrial fibrillation cardioversion, reliable, less adverse reactions, it is worth promoting.